Core Laboratories (NYSE:CLB – Get Free Report) released its quarterly earnings data on Wednesday. The oil and gas company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23, Zacks reports. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. Core Laboratories updated its Q1 2025 guidance to 0.120-0.160 EPS.
Core Laboratories Stock Down 0.1 %
Shares of Core Laboratories stock traded down $0.01 on Wednesday, hitting $18.52. The company had a trading volume of 364,199 shares, compared to its average volume of 271,050. The stock has a 50-day moving average of $19.04 and a 200-day moving average of $19.50. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. Core Laboratories has a twelve month low of $13.82 and a twelve month high of $25.13. The firm has a market capitalization of $869.42 million, a P/E ratio of 28.49, a P/E/G ratio of 1.14 and a beta of 2.39.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on CLB. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup reduced their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.00.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories
- Five stocks we like better than Core Laboratories
- Profitably Trade Stocks at 52-Week Highs
- 3 Steel Stocks Soaring After Tariff Announcements
- The 3 Best Blue-Chip Stocks to Buy Now
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- The How And Why of Investing in Oil Stocks
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.